Bespoke Extracts, Inc. Stock

Equities

BSPK

US08634Q2084

Pharmaceuticals

Market Closed - OTC Markets 11:17:32 2024-04-30 EDT 5-day change 1st Jan Change
0.12 USD +98.35% Intraday chart for Bespoke Extracts, Inc. +9.19% +238.03%
Sales 2022 3.41K 4.68K Sales 2023 785K 1.08M Capitalization 361K 496K
Net income 2022 -4M -5.49M Net income 2023 -1M -1.37M EV / Sales 2022 699 x
Net Debt 2022 671K 922K Net Debt 2023 1.11M 1.53M EV / Sales 2023 1.87 x
P/E ratio 2022
-0.46 x
P/E ratio 2023
-0.24 x
Employees 2
Yield 2022 *
-
Yield 2023
-
Free-Float 84.17%
More Fundamentals * Assessed data
Dynamic Chart
Bespoke Extracts, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Bespoke Extracts, Inc. announced that it has received $0.1 million in funding CI
Bespoke Extracts, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
Bespoke Extracts, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
Bespoke Extracts, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Bespoke Extracts, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Bespoke Extracts, Inc. Auditor Raises 'Going Concern' Doubt CI
Bespoke Extracts, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022 CI
Bespoke Extracts, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022 CI
Bespoke Extracts, Inc. entered into a definitive agreement to acquire the Assets of Osiris, LLC for $1.58 million. CI
Bespoke Extracts, Inc. announced that it has received $0.0922 million in funding from Infinity Management LLC and other investors CI
Bespoke Extracts, Inc. announced that it expects to receive $0.0922 million in funding from Infinity Management LLC and other investors CI
Bespoke Extracts, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
Bespoke Extracts, Inc. Reports Earnings Results for the Four Months Ended December 31, 2021 CI
Bespoke Extracts, Inc. Reports Earnings Results for the Four Months Ended December 31, 2021 CI
More news
1 day+98.35%
1 week+9.19%
Current month+2.56%
1 month-7.69%
3 months+20.00%
6 months-11.11%
Current year+238.03%
More quotes
1 week
0.05
Extreme 0.054925
0.12
1 month
0.05
Extreme 0.054925
0.16
Current year
0.02
Extreme 0.0186
1.00
1 year
0.02
Extreme 0.0186
1.00
3 years
0.02
Extreme 0.0186
1.78
5 years
0.02
Extreme 0.0186
4.57
10 years
0.02
Extreme 0.0186
135.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 53 21-11-18
President 35 21-10-31
Members of the board TitleAgeSince
Chief Executive Officer 53 21-11-18
President 35 21-10-31
More insiders
Date Price Change Volume
24-04-30 0.12 +98.35% 134,379
24-04-29 0.0605 -34.59% 16,380
24-04-26 0.0925 -15.83% 367
24-04-24 0.1099 -.--% 5,001

Delayed Quote OTC Markets, April 30, 2024 at 11:17 am

More quotes
Bespoke Extracts, Inc. operates in the regulated cannabis markets in the United States. The Company owns, manufactures, and distributes a portfolio of cannabis consumer packaged goods brands including Fresh Joints, Box-O-Joints, and Wee Joints, to licensed marijuana dispensaries across Colorado. Through its wholly owned subsidiary, Bespoke Extracts Colorado, LLC, the Company operates Wonderleaf LLC (WonderLeaf), a marijuana-infused products production facility in Aurora, Colorado. The Company manufactures a range of premium pre-rolled joints. The Company has offered cannabis products focusing on two primary categories: Branded Products and Processing Business. It plans to pursue production of brands of pre-rolled joints and other processed marijuana products under newly created brand names. It also plans to explore licensing existing brands from other states and producing them in Colorado.
More about the company